Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (1y) (2010 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | -308.05% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.71% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 118.07% |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | -362.36% |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn | 7.00% |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 55.80% |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 7,279.20% |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -308.05% |
| Mar 31, 2026 | 13.93% |
| Dec 31, 2025 | -18.32% |
| Sep 30, 2025 | -49.63% |
| Jun 30, 2025 | 32.58% |
| Mar 31, 2025 | 39.58% |
| Dec 31, 2024 | -32.89% |
| Sep 30, 2024 | 45.65% |
| Jun 30, 2024 | -41.06% |
| Mar 31, 2024 | -20.44% |
| Dec 31, 2023 | 79.17% |
| Sep 30, 2023 | 25.17% |
| Jun 30, 2023 | 68.72% |
| Mar 31, 2023 | 12.42% |
| Dec 31, 2022 | -31.71% |
| Sep 30, 2022 | -48.96% |
| Jun 30, 2022 | -62.79% |
| Mar 31, 2022 | -68.31% |
| Dec 31, 2021 | 74.47% |
| Sep 30, 2021 | 83.44% |